Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.
Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.
Should communities push local restaurants toward offering healthier foods? A new report offers some resources and ideas for your reporting.
Toxic hair straightening, a new drug for cystic fibrosis, a religious battle over birth control and more from our Daily Briefing.
The safety of bagged salads, Special K (not the cereal) for depression, FDA whistleblowers sue, and more from our Daily Briefing.
A reprieve for federal long-term care legislation, a possible FBI investigation of a hospital chain, and woes for Lap-Band marketers, plus more in our Daily Briefing.
There’s plenty of of analysis, criticism and praise of HHS Secretary Kathleen Sebelius’ controversial decision on the “morning after” contraceptive pill Plan B. Here's a look at the national conversation.
A moving examination of how doctors choose to die, a big-money Prempro lawsuit, and FDA scrutiny of the HCG diet, plus more from our Daily Briefing.
I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.
Correcting a genetic defect before birth sounds like a great idea, but I'm uncomfortable with how we get there.
